Literature DB >> 8270163

Extracellular matrix components and amyloid in neuritic plaques of Alzheimer's disease.

E Brandan1, N C Inestrosa.   

Abstract

1. There has been an enormous amount of information relating to the molecular components involved in Alzheimer's disease. 2. Recently some attention has been focused on the extracellular matrix (ECM) components present in the brain amyloid deposits. 3. Here we discuss, the direct involvement of ECM constituents such as laminin, collagen type IV, fibronectin, proteoglycans (PGs) and basic fibroblast growth factor in the formation of neuritic plaques. 4. We suggest that PGs act as nucleating agents in the formation of the diffuse amyloid deposits that precede the formation of the neuritic plaque in the brain of patients affected with Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8270163     DOI: 10.1016/0306-3623(93)90350-7

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  7 in total

1.  Agrin in Alzheimer's disease: altered solubility and abnormal distribution within microvasculature and brain parenchyma.

Authors:  J E Donahue; T M Berzin; M S Rafii; D J Glass; G D Yancopoulos; J R Fallon; E G Stopa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

2.  Significantly reduced expression of the proteoglycan decorin in Alzheimer's disease fibroblasts.

Authors:  E Brandan; F Melo; M García; M Contreras
Journal:  Clin Mol Pathol       Date:  1996-12

3.  Epithelial cells augment barrier function via activation of the Toll-like receptor 2/phosphatidylinositol 3-kinase pathway upon recognition of Salmonella enterica serovar Typhimurium curli fibrils in the gut.

Authors:  Gertrude O Oppong; Glenn J Rapsinski; Tiffanny N Newman; Jessalyn H Nishimori; Steven G Biesecker; Çagla Tükel
Journal:  Infect Immun       Date:  2012-12-03       Impact factor: 3.441

Review 4.  The Physiological and Pathological Implications of the Formation of Hydrogels, with a Specific Focus on Amyloid Polypeptides.

Authors:  Létitia Jean; Alex C Foley; David J T Vaux
Journal:  Biomolecules       Date:  2017-09-22

5.  GJA1 (connexin43) is a key regulator of Alzheimer's disease pathogenesis.

Authors:  Yuji Kajiwara; Erming Wang; Minghui Wang; Wun Chey Sin; Kristen J Brennand; Eric Schadt; Christian C Naus; Joseph Buxbaum; Bin Zhang
Journal:  Acta Neuropathol Commun       Date:  2018-12-21       Impact factor: 7.801

6.  Multi-omic analyses in Abyssinian cats with primary renal amyloid deposits.

Authors:  Francesca Genova; Simona Nonnis; Elisa Maffioli; Gabriella Tedeschi; Maria Giuseppina Strillacci; Michela Carisetti; Giuseppe Sironi; Francesca Anna Cupaioli; Noemi Di Nanni; Alessandra Mezzelani; Ettore Mosca; Christopher R Helps; Peter A J Leegwater; Laetitia Dorso; Maria Longeri
Journal:  Sci Rep       Date:  2021-04-16       Impact factor: 4.379

7.  Icariin ameliorates neuropathological changes, TGF-β1 accumulation and behavioral deficits in a mouse model of cerebral amyloidosis.

Authors:  Zhi-Yuan Zhang; Chaoyun Li; Caroline Zug; Hermann J Schluesener
Journal:  PLoS One       Date:  2014-08-07       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.